2024. Maintenance of Response to Risankizumab in Patients With Psoriatic Arthritis: A 4-Year Analysis of the KEEPsAKE 1 and 2 Trials. SKIN The Journal of Cutaneous Medicine. 8, 6 (Nov. 2024), s444. DOI:https://doi.org/10.25251/skin.8.supp.444.